Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Al Qaeda, ISIS could Pose Threat in 2 Years

Al Qaeda could pose a threat from Afghanistan to the U.S.…
Read more

Bennett: ‘Wake Up’ on Iran Nuke Deal

Israeli Prime Minister Naftali Bennet said the presidential…
Read more

Democrat Suggests Stripping Catholic Church Of Tax-Exemption If Biden Denied Communion

Rep. Jared Huffman (D-CA) suggested stripping the Catholic…
Read more